
    
      Prospective single blinded randomized controlled clinical trial on critically ill Pneumonic
      patients, included two groups, over one year period. The first group will be administered
      intravenous (IV) linezolid 600mg twice daily. The second group will be prescribed linezolid
      (IV) 600 mg loading dose followed by 1200 mg by continous infusion. Both groups will be
      co-administered intravenous (IV) beta lactam empirically.
    
  